The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

2003

Stage

Series C | Alive

Total Raised

$20M

Last Raised

$20M | 16 yrs ago

About The Vaccine Company

The Vaccine Company is a Healthcare/Medical Product Distribution company based in South San Francisco, California. The Vaccine Company has received investment from Investbio.

The Vaccine Company Headquarter Location

601 Gateway Boulevard Suite 450

South San Francisco, California, 94080,

United States

650-244-4100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

The Vaccine Company Patents

The Vaccine Company has filed 9 patents.

The 3 most popular patent topics include:

  • Applied genetics
  • Biotechnology
  • Gene delivery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/12/2016

4/9/2019

Molecular biology, RNA, Gene expression, Genetics, Biotechnology

Grant

Application Date

2/12/2016

Grant Date

4/9/2019

Title

Related Topics

Molecular biology, RNA, Gene expression, Genetics, Biotechnology

Status

Grant

Latest The Vaccine Company News

New £4.3m Challenge Study Contract Win with Global Top 10 Vaccine Company

Sep 29, 2020

New £4.3m Challenge Study Contract Win with Global Top 10 Vaccine Company Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce a new £4.3 million contract to conduct a human viral challenge study utilising one of our 8 traditional challenge study models for another of the global top 10 vaccine companies. This trial will be conducted in the Company's dedicated human viral challenge quarantine unit in London with all volunteers recruited through hVIVO's volunteer recruitment website,  www.flucamp.com . The hVIVO unit is Europe's only commercial 24-bedroom quarantine clinic with on-site virology laboratory. Work on this major new contract has started already and the contract is expected to be delivered in Q1 2021 with the majority of revenues being generated in H1 2021. It is a further example of Open Orphan delivering on its pipeline and stated strategy of winning sizeable contracts. The Company's Interim Results will be published on the morning of Wednesday the 30th of September 2020, analyst conference call scheduled for 10.30am on the 30th of September. "Open Orphan continues to execute on its substantial pipeline that has been built up by the expertise and experience of our professional and hardworking teams in  hVIVO  and  Venn Life Sciences . We are focused on continuing to deliver large and profitable contracts which demonstrate hVIVO's position as the world leader in the testing of vaccines and antivirals using human challenge clinical trials. Our stated objectives when we acquired hVIVO in January of this year was to increase its 24-bedroom quarantine clinic annual utilisation from its traditional 20-25% utilisation up to maximum capacity and to build out a clear pipeline of signed contracts going forward. With this contract, we are close to having the hVIVO quarantine clinic block booked with our conventional challenge studies until December 2021. Within a month or two we are likely to have our quarantine clinic block booked out for the next 18 months to two years with conventional challenge study contracts. I am hugely excited by the progress we are making as a Group since our IPO in 2019 and I look forward to continuing to update shareholders on the work we are doing over the coming months."   Interested in becoming a volunteer? hVIVO recruits many of its volunteers for its challenge study clinical trials through its dedicated volunteer recruitment website,  www.flucamp.com . hVIVO welcomes volunteers to take part in our clinical trials under expertly supervised conditions, to further medical research, and help us to take the understanding of respiratory illnesses to a new level. Volunteers are central to the work that we do; our studies focus on testing new treatments on real people, in a safe, controlled, clinical environment. Further details on all aspects of our volunteer programs including testimonials from previous volunteers can be found at www.flucamp.com . The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. Editor Details

  • When was The Vaccine Company founded?

    The Vaccine Company was founded in 2003.

  • Where is The Vaccine Company's headquarters?

    The Vaccine Company's headquarters is located at 601 Gateway Boulevard, South San Francisco.

  • What is The Vaccine Company's latest funding round?

    The Vaccine Company's latest funding round is Series C.

  • How much did The Vaccine Company raise?

    The Vaccine Company raised a total of $20M.

  • Who are the investors of The Vaccine Company?

    Investors of The Vaccine Company include Investbio.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.